APA (7th ed.) Citation

PE, P., M, D., S, F., M, C., VS, M., MT, S., . . . MH, D. (2021). Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of the American Society of Nephrology : JASN, 32(1), 211. https://doi.org/10.1681/ASN.2020050595

Chicago Style (17th ed.) Citation

PE, Pergola, et al. "Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." Journal of the American Society of Nephrology : JASN 32, no. 1 (2021): 211. https://doi.org/10.1681/ASN.2020050595.

MLA (9th ed.) Citation

PE, Pergola, et al. "Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." Journal of the American Society of Nephrology : JASN, vol. 32, no. 1, 2021, p. 211, https://doi.org/10.1681/ASN.2020050595.